Harry G Mond1, Ian Crozier2. 1. Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Vic, Australia. Electronic address: hmond@bigpond.net.au. 2. Christchurch Hospital, Christchurch, New Zealand.
Abstract
BACKGROUND: A cardiac implantable electronic device (CIED) survey was undertaken in Australia and New Zealand for calendar year 2017 and involved pacemakers (PMs) and implantable cardioverter-defibrillators (ICDs). RESULTS AND CONCLUSIONS: For 2017, there were 17,971 (15,203 in 2013) new PMs sold in Australia and 1,811 (1,641 in 2013) implanted in New Zealand. The number of new PM implants per million population was 745 for Australia (652 in 2013) and 384 for New Zealand (367 in 2013). In both Australia and New Zealand, the number of PM replacements fell as a result of improved power source service life. Pulse generator types implanted were predominantly dual chamber; Australia 73% (74% in 2013) and New Zealand 68% (59% in 2013). There were 1,247 biventricular PMs implanted in Australia (661 in 2013) and 118 in New Zealand (83 in 2013). Transvenous pacing leads were overwhelmingly active fixation in both the atrium and ventricle. In Australia there was an increase in ICD usage with 4,212 new implants (3,904 in 2013), but a small fall in New Zealand to 396 (423 in 2013). The new ICD implants per million population were 175 for Australia (167 in 2013) and 90 for New Zealand (95 in 2013). There was a small reduction in biventricular ICDs in both Australia (2,195) and New Zealand (111).
BACKGROUND: A cardiac implantable electronic device (CIED) survey was undertaken in Australia and New Zealand for calendar year 2017 and involved pacemakers (PMs) and implantable cardioverter-defibrillators (ICDs). RESULTS AND CONCLUSIONS: For 2017, there were 17,971 (15,203 in 2013) new PMs sold in Australia and 1,811 (1,641 in 2013) implanted in New Zealand. The number of new PM implants per million population was 745 for Australia (652 in 2013) and 384 for New Zealand (367 in 2013). In both Australia and New Zealand, the number of PM replacements fell as a result of improved power source service life. Pulse generator types implanted were predominantly dual chamber; Australia 73% (74% in 2013) and New Zealand 68% (59% in 2013). There were 1,247 biventricular PMs implanted in Australia (661 in 2013) and 118 in New Zealand (83 in 2013). Transvenous pacing leads were overwhelmingly active fixation in both the atrium and ventricle. In Australia there was an increase in ICD usage with 4,212 new implants (3,904 in 2013), but a small fall in New Zealand to 396 (423 in 2013). The new ICD implants per million population were 175 for Australia (167 in 2013) and 90 for New Zealand (95 in 2013). There was a small reduction in biventricular ICDs in both Australia (2,195) and New Zealand (111).
Authors: Fang Shawn Foo; Mildred Lee; Khang-Li Looi; Peter Larsen; Geoffrey C Clare; David Heaven; Martin K Stiles; Jamie Voss; Dean Boddington; Rod Jackson; Andrew J Kerr Journal: J Arrhythm Date: 2019-10-06
Authors: Hossein Aslian; Tomas Kron; Troy Watts; Cagla Akalanli; Nicholas Hardcastle; Peta Lonski; Atousa Montaseri; Barry Hay; James Korte; Kemal Berk; Francesco Longo; Mara Severgnini Journal: J Appl Clin Med Phys Date: 2020-04-11 Impact factor: 2.102
Authors: Peter R S Stijnman; Bart R Steensma; Cornelis A T van den Berg; Alexander J E Raaijmakers Journal: Sci Rep Date: 2022-03-10 Impact factor: 4.379